{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:31:17Z","timestamp":1774078277026,"version":"3.50.1"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11,1]]},"DOI":"10.1164\/rccm.201409-1609le","type":"journal-article","created":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T14:03:53Z","timestamp":1414764233000},"page":"1075-1076","source":"Crossref","is-referenced-by-count":1,"title":["Reply: Azithromycin: We're There!"],"prefix":"10.1093","volume":"190","author":[{"given":"Marcos","family":"I. Restrepo","sequence":"first","affiliation":[{"name":"South Texas Veterans Health Care System, and, University of Texas Health Science Center, San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Anzueto","sequence":"additional","affiliation":[{"name":"South Texas Veterans Health Care System, and, University of Texas Health Science Center, San Antonio, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,11,1]]},"reference":[{"key":"2026032100291528000_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1164\/rccm.201406-1014ED","article-title":"Macrolide antibiotics for prevention of chronic obstructive pulmonary disease exacerbations: are we there yet? [editorial]","volume":"190","author":"Restrepo","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100291528000_bib2","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1164\/rccm.201402-0207OC","article-title":"Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy","volume":"189","author":"Han","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100291528000_bib3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"key":"2026032100291528000_bib4"},{"key":"2026032100291528000_bib5","author":"Centers for Disease Control and Prevention","year":"2013"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/190\/9\/1075\/67218195\/ajrccm_190_9_1075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/190\/9\/1075\/67218195\/ajrccm_190_9_1075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:29:24Z","timestamp":1774067364000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/190\/9\/1075\/8505258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,1]]},"references-count":5,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,11,1]]},"published-print":{"date-parts":[[2014,11,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201409-1609le","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,11]]},"published":{"date-parts":[[2014,11,1]]}}}